Ian Sheffield Biography and Net Worth

Director of Fractyl Health

Ian Sheffield is Managing Partner at North Country Holdings, a private investment firm focused on acquiring and growing U.S.-based businesses. He has more than 20 years of experience as a healthcare investor and medtech executive, with senior roles at Ashler Capital (Citadel), Bridger Capital, Great Point Partners, and Versant Ventures. Earlier, he held operating positions at Medtronic and Procter & Gamble, leading teams in strategy, commercialization, and business management. He has served on the boards of both public and private medical technology companies. Mr. Sheffield holds a B.S. from Miami University and an M.B.A. from Harvard Business School

What is Ian Sheffield's net worth?: The estimated net worth of Ian Sheffield is at least $25.96 thousand as of June 10th, 2026. Mr. Sheffield owns 35,000 shares of Fractyl Health stock worth more than $25,963 as of August 28th. This net worth approximation does not reflect any other investments that Mr. Sheffield may own. Learn More about Ian Sheffield's net worth.
How do I contact Ian Sheffield?: The corporate mailing address for Mr. Sheffield and other Fractyl Health executives is 17 Hartwell Avenue, Lexington, MA 02421, United States. Fractyl Health can also be reached via phone at 781-902-8800 and via email at [email protected]. Learn More on Ian Sheffield's contact information.
Has Ian Sheffield been buying or selling shares of Fractyl Health?: Ian Sheffield has not been actively trading shares of Fractyl Health within the last three months. Most recently, on Wednesday, June 10th, Ian Sheffield bought 35,000 shares of Fractyl Health stock. The stock was acquired at an average cost of $0.73 per share, with a total value of $25,550.00. Following the completion of the transaction, the director now directly owns 35,000 shares of the company's stock, valued at $25,550. Learn More on Ian Sheffield's trading history.
Who are Fractyl Health's active insiders?: Fractyl Health's insider roster includes Harith Rajagopalan (CEO), Ajay Royan (Director), and Ian Sheffield (Director). Learn More on Fractyl Health's active insiders.
Are insiders buying or selling shares of Fractyl Health?: During the last twelve months, Fractyl Health insiders bought shares 6 times. They purchased a total of 181,909 shares worth more than $147,148.61. The most recent insider tranaction occured on June, 12th when Director Ajay Royan bought 23,000 shares worth more than $19,550.00. Insiders at Fractyl Health own 8.5% of the company. Learn More about insider trades at Fractyl Health.
Information on this page was last updated on 6/12/2026.

Ian Sheffield Insider Trading History at Fractyl Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/10/2026	Buy	35,000	$0.73	$25,550.00	35,000

Ian Sheffield Buying and Selling Activity at Fractyl Health

Fractyl Health Company Overview

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $0.74

$0.74

$0.76

50 Day Range

MA: $0.75

$0.66

$0.91

2 Week Range

Now: $0.74

$0.38

$2.45

Volume

56,479 shs

Average Volume

3,196,592 shs

Market Capitalization

$117.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32